Regulation of Pseudomonas aeruginosa corneal infection in IL-1β converting enzyme (ICE, caspase-1) deficient mice

Current Eye Research

Volumn 29, Issue 4-5, 2004, Pages 225-233

  Thakur, Archana ^a   Barrett, Ronald P ^a   McClellan, Sharon ^a   Hazlett, Linda D ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Caspase 1 deficiency; Immune regulation; Keratitis; Pseudomonas aeruginosa

Indexed keywords

CHEMOKINE; CYTOKINE; INTERLEUKIN 1BETA; INTERLEUKIN 1BETA CONVERTING ENZYME; MYELOPEROXIDASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY DETECTION; ARTICLE; CONTROLLED STUDY; ENZYME DEFICIENCY; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME REGULATION; FEMALE; IMMUNE RESPONSE; IMMUNOREGULATION; INFLAMMATION; KERATITIS; KNOCKOUT MOUSE; MOUSE; NICK END LABELING; NONHUMAN; POLYMORPHONUCLEAR CELL; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; QUANTITATIVE DIAGNOSIS; REGULATORY MECHANISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCORING SYSTEM; THROMBOCYTE COUNT; WILD TYPE;

ANIMALS; CASPASE 1; CHEMOKINES; COLONY COUNT, MICROBIAL; CORNEAL ULCER; ENZYME-LINKED IMMUNOSORBENT ASSAY; EYE INFECTIONS, BACTERIAL; FEMALE; IN SITU NICK-END LABELING; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; INTERLEUKIN-1; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NEUTROPHILS; PEROXIDASE; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SIALOGLYCOPROTEINS;

EID: 11844299050     PISSN: 02713683     EISSN: None     Source Type: Journal    
DOI: 10.1080/02713680490516710     Document Type: Article

References (29)

1. Kernacki KA, Berk RS. Characterization of the inflammatory response induced by corneal infection induced by Pseudomonas aeruginosa. J Ocular Pharmacol. 1994;10: 281-288.
2. Kernacki KA, Hobden JA, Hazlett LD, Fridman R, Berk RS. In vivo bacterial protease production during Pseudomonas aeruginosa corneal infection. Invest Ophthalmol Vis Sci. 1995;36:1371-1377.
3. Steuhl KP, Doring G, Theil HJ. The significance of bacterial and host factors in corneal infections caused by Pseudomonas aeruginosa. Fortschr Ophthalmol. 1989;86: 283-289.
4. Yan XT, Tumpey TM, Kunkel SL, Oakes JE, Lausch RN. Role of MIP-2 in neutrophil migration and tissue injury in the herps simplex virus-1-infected cornea. Invest Ophthalmol Vis Sci. 1998;39:1854-1862.
5. Dana MR, Yamada J, Streilein JW. Topical interleukin 1 receptor antagonist promotes corneal transplant survival. Transplantation. 1997;63:1501-1507.
6. Rudner XL, Kernacki KA, Barren RP, Hazlett LD. Prolonged elevation of IL-1 in Pseudomonas aeruginosa ocular infection regulates macrophage- inflammatory protein-2 production, polymorphonuclear neutrophil persistence, and corneal perforation. J Immunol. 2000;164: 6576-6582.
7. Thakur A, Xue M, Stapleton F, Lloyd AR, Wakefield D, Willcox MDP. Balance of pro- and anti-inflammatory cytokines correlates with outcome of acute experimental Pseudomonas aeruginosa keratitis. Infect Immun. 2002;70: 2187-2197.
8. Kuida K, Lippke JA, Ku G, Harding MW, Livingston DJ, Su MS, Flavell RA. Altered cytokine export and apoptosis in mice deficient in interleukin-1 beta converting enzyme. Science. 1995;267:2000-2003.
9. + T cell-dependent keratitis with genetic susceptibility to Pseudomonas aeruginosa ocular infection. J Immunol. 1997;159:6283-6290.
10. Hazlett LD, Moon MM, Strejc M, Berk RS. Evidence for N-acetylmannosamine as an ocular receptor for P. aeruginosa adherence to scarified cornea. Invest Ophthalmol Vis Sci. 1987;28:1978-1985.
11. Williams RN, Patterson CA, Eakins KE. Quantitation of ocular inflammation: Evaluation of polymorphonuclear leukocyte inflammation by measuring myeloperoxidase activity. Curr Eye Res. 1983;2:465-470.
12. Gabay C, Porter B, Fantuzzi G, Arend WP. Mouse IL-1 receptor antagonist isoforms: Complementary DNA cloning and protein expression of intracellular isoform and tissue distribution of secreted and intracellular IL-1 receptor antagonist in vivo. J Immunol 1997;159:5905-5913.
13. Fantuzzi G, Ku G, Harding MW, Livingston DJ, Sipe JD, Kuida K, Flavell RA, Dinarello CA. Response to local inflammation of IL-1 beta-converting enzyme-deficient mice. J Immunol. 1997;158:1818-1824.
14. Khatri S, Lass JH, Heinzel FP, Petroll WM, Gomez J, Diaconu E, Kalsow CM, Pearlman E. Regulation of endotoxin-induced keratitis by PECAM-1, MIP-2, and toll-like receptor 4. Invest Ophthalmol Vis Sci. 2002;43: 2278-2284.
15. Hazuda DJ, Strickler J, Kueppers F, Simon PL, Young PR. Processing of precursor interleukin 1 beta and inflammatory disease. J Biol Chem. 1990;265:6318-6322.
16. Coeshott C, Ohnemus C, Pilyavskaya A, Ross S, Wieczorek M, Kroona H. Converting enzyme-independent release of tumor necrosis factor and IL-1 from a stimulated human monocytic cell line in the presence of activated neutrophils or purified proteinase 3 (neutrophil elastase/cytokine processing/proteinase inhibitors). Proc Natl Acad Sci. 1999;96:6261-6266.
17. Schonbeck U, Mach F, Libby P. Generation of biologically active IL-1 beta by matrix metalloproteinases: A novel caspase-1-independent pathway of IL-1 beta processing. J Immunol. 1998;161:3340-3346.
18. Kapur V, Majesky MW, Li L, Black RA, Musser JM. Cleavage of interleukin 1β (IL-1β) precursor to produce active IL-1β by a conserved extracellular cysteine protease from Streptococcus pyogenes. Proc Natl Acad Sci. 1993;90:7676-7680.
19. Black RA, Kronheim SR, Cantrell M, Deeley MC, March CJ, Prickelt KS, Wignall J, Conlon PJ, Cosman D, Hopp TP et al. Generation of biologically active interleukin-1 beta by proteolytic cleavage of the inactive precursor. J Biol Chem. 1988;263:9437-9442.
20. Sansonetti PJ, Arondel J, Cavaillon JM, Huerre M. Role of interleukin-1 in the pathogenesis of experimental shigellosis. J Clin Invest. 1995;96:884-892.
21. Arend WP, Malyak M, Guthridge CJ, Gabay C. Interleukin-1 receptor antagonist: Role in biology. Annu Rev Immunol. 1998;16:27-32.
22. Eisenberg SP, Evans RJ, Arend WP, Verderber E, Brewer MT, Hannum CH, Thompson RC. Primary structure and functional expression from complementary DNA of a human interleukin-1 receptor antagonist. Nature. 1990;343:341-346.
23. Chai Z, Gatti S, Toniatti C, Poli V, Bartfai T. Interleukin (IL)-6 gene expression in the central nervous system is necessary for fever response to lipopolysaccharide or IL-1 beta: A study on IL-6-deficient mice. J Exp Med. 1996;183:311-316.
24. Gu Y, Kuida K, Tsutsui H, Ku G, Hsiao K, Fleming MA, Hayashi N, Higashino K, Okamura H, Nakanishi K, Kurimoto M, Tanimoto T, Flavell RA, Sato V, Harding MW, Livingston DJ, Su MS. Activation of interferon-gamma inducing factor mediated by interleukin-1 beta converting enzyme. Science. 1997;275:206-209.
25. Huang X, McClellan SA, Barren RP, Hazlett LD. IL-18 contributes to host resistance against infection with Pseudomonas aeruginosa through induction of IFN-gamma production. J Immunol. 2002;168:5756-5763.
26. Cole N, Bao S, Stapleton F, Thakur A, Husband AJ, Beagley KW, Willcox MD. Pseudomonas aeruginosa keratitis in IL-6-deficient mice. Int Arch Allergy Immunol. 2003;130: 165-172.
27. Savill J. Apoptosis in resolution of inflammation. J Leukoc Biol. 1997;6:375-380.
28. Grassme H, Kirschnek S, Riethmueller J, Riehle A, von Kurthy G, Lang F, Weller M, Gulbins E. CD95/ CD95 ligand interactions on epithelial cells in host defense to Pseudomonas aeruginosa. Science. 2000;290:527-530.
29. Rowe SJ, Allen L, Ridger VC, Hellewell PG, Whyte MK. Caspase-1-deficient mice have delayed neutrophil apoptosis and a prolonged inflammatory response to lipopolysaccharide-induced acute lung injury. J Immunol. 2002;169:6401-6407.